While the stock of Johnson & Johnson (JNJ) has the same value it had ten years ago, the company has doubled sales and increased earnings per share 116% over the same time period. Perhaps more importantly, they have increased their dividend by 221%, boosting it every year; the stock now yields 3.5%.
Cute, but, this is old news. You're dealing with a much more sophisticated consumer than you did in past years. People are tired of being deceived. This information includes JNJ's earlier successes when it was a different company. We want it to go "Back to the Future". It needs a very bad excision surgery, i.e., get rid of the current BOD and Senior Management... this is bad DNA.